Immunobiology of cholangiocarcinoma
-
Published:2023-09
Issue:3
Volume:79
Page:867-875
-
ISSN:0168-8278
-
Container-title:Journal of Hepatology
-
language:en
-
Short-container-title:Journal of Hepatology
Author:
Tomlinson Jennifer L.,
Valle Juan W.ORCID,
Ilyas Sumera I.ORCID
Reference84 articles.
1. Cholangiocarcinoma — evolving concepts and therapeutic strategies;Rizvi;Nat Rev Clin Oncol,2018
2. Cholangiocarcinoma 2020: the next horizon in mechanisms and management;Banales;Nat Rev Gastroenterol Hepatol,2020
3. Cholangiocarcinoma;Brindley;Nat Rev Dis Primers,2021
4. Addition of ramucirumab or merestinib to standard first-line chemotherapy for locally advanced or metastatic biliary tract cancer: a randomised, double-blind, multicentre, phase 2 study;Valle;Lancet Oncol,2021
5. Gemcitabine and cisplatin plus durvalumab with or without tremelimumab in chemotherapy-naive patients with advanced biliary tract cancer: an open-label, single-centre, phase 2 study;Oh;Lancet Gastroenterol Hepatol,2022
Cited by
3 articles.
订阅此论文施引文献
订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献